Submit Your Article CMED MEACR meeting
Home Print this page Email this page Users Online: 1242
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2014  |  Volume : 3  |  Issue : 6  |  Page : 487-492

GSTP1 expression and promoter methylation in epithelial ovarian carcinoma


1 Department of Biochemistry, Kidwai Memorial Institute of Oncology, Shankarpuram, Basavanagudi, Bangalore, Karnataka, India
2 Department of Pathology, Kidwai Memorial Institute of Oncology, Shankarpuram, Basavanagudi, Bangalore, Karnataka, India
3 Department of Gynec Oncology, Kidwai Memorial Institute of Oncology, Shankarpuram, Basavanagudi, Bangalore, Karnataka, India
4 Department of Biochemistry, Kidwai Memorial Institute of Oncology; Department of Biochemistry, Sri Shankara Cancer Hospital and Research Centre, Shankarpuram, Basavanagudi, Bangalore, Karnataka, India

Correspondence Address:
Lakshmi Krishnamoorthy
Sri Shankara Cancer Hospital and Research Centre, 1st Cross, Shankarpuram, Basavanagudi, Bangalore - 560 004, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2278-0513.142621

Rights and Permissions

Context: GSTP1 is a subgroup of glutathione-S-transferase family, which provides cellular protection against free radical and carcinogenic compounds due to its detoxifying function. Altered GSTP1 activity due to down regulation of enzyme activity and DNA methylation has been reported in many tumors, although data for ovarian cancer are few. In this study, we aimed at determining the expression of GSTP1 in relation to the methylation of the GSTP1 promoter in epithelial ovarian cancer (EOC). Materials and Methods: GSTP1 mRNA expression and GSTP1 enzyme concentration were assessed by quantitative reverse transcriptase polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay, respectively, in 88 EOCs, 14 low malignant potential (LMP) tumors, and 20 benign tumors. The promoter methylation of GSTP1 gene was evaluated by methylation-specific PCR. Results: Reduced GSTP1 mRNA expression was observed in 49% EOCs, 21.4% LMP, and 45% benign tumors. Significantly lower levels of plasma GSTP1 were observed in all tumor samples compared to normal. GSTP1 promoter methylation was detected in 10 (11.4%) EOCs and 1 (7.3%) LMP tumors. No methylation was observed in benign tumors and normal ovaries. Conclusions: Our results show that there is a significant down regulation of GSTP1 expression while hypermethylation of the GSTP1 gene promoter is not very frequent in EOC. Further studies are needed to study underlying mechanisms leading to decreased expression.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2240    
    Printed39    
    Emailed0    
    PDF Downloaded55    
    Comments [Add]    
    Cited by others 2    

Recommend this journal